2.4.2.6	6-methylthio-GMP	competitive versus dGMP	62494	
2.4.2.6	adenine	-	144	
2.4.2.6	amino-pyrrolo-pyrimidine	12.1 mM, complete inhibition of the reaction with adenine and deoxycytidine	112041	
2.4.2.6	Ca2+	inhibits base exchange activity at 1 mM	15	
2.4.2.6	CO2	reduces base exchange activity by 87-99% at 1 mM	28	
2.4.2.6	Cu2+	reduces base exchange activity by 87-99% at 1 mM	19	
2.4.2.6	cytosine	-	489	
2.4.2.6	deoxyadenosine	-	601	
2.4.2.6	deoxyadenosine	linear competitive inhibition of deoxyinosine and linear non-competitive inhibition of adenine	601	
2.4.2.6	deoxyadenosine	linear competitive inhibition of deoxycytidine	601	
2.4.2.6	deoxycytidine	-	451	
2.4.2.6	deoxyinosine	-	1104	
2.4.2.6	EDTA	strong inhibition	21	
2.4.2.6	GMP	competitive versus dGMP	162	
2.4.2.6	Hydroxypyrrolopyrimidine	0.33 mM, 66% inhibition of the reaction with adenine and deoxycytidine	97995	
2.4.2.6	hypoxanthine	-	211	
2.4.2.6	imidazole	12.1 mM, 76% inhibition of the reaction with adenine and deoxycytidine	470	
2.4.2.6	Mg2+	inhibits base exchange activity at 1mM	6	
2.4.2.6	Mg2+	strong inhibition	6	
2.4.2.6	Mn2+	reduces base exchange activity by 87-99% at 1 mM	11	
2.4.2.6	NaCl	70% activity remains at 1 M NaCl	42	
2.4.2.6	NaCl	activity decreases 25% in presence of 1.5 M NaCl	42	
2.4.2.6	Tris	-	317	
2.4.2.6	Tris	complete inhibition of deoxyribosyltransferase I at 0.1 M, pH 6.9. 62% inhibition of nucleoside deoxyribosyltransferase I at 0.8 M, pH 5.9	317	
2.4.2.6	Zn2+	-	14	
2.4.2.6	Zn2+	reduces base exchange activity by 87-99% at 1 mM	14